Arnold Reynaldi

8.7k total citations · 1 hit paper
36 papers, 3.6k citations indexed

About

Arnold Reynaldi is a scholar working on Infectious Diseases, Immunology and Virology. According to data from OpenAlex, Arnold Reynaldi has authored 36 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 14 papers in Immunology and 8 papers in Virology. Recurrent topics in Arnold Reynaldi's work include SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (11 papers) and HIV Research and Treatment (8 papers). Arnold Reynaldi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (11 papers) and HIV Research and Treatment (8 papers). Arnold Reynaldi collaborates with scholars based in Australia, United States and Kenya. Arnold Reynaldi's co-authors include Miles P. Davenport, Stephen J. Kent, Adam K. Wheatley, Deborah Cromer, Jennifer A. Juno, David S. Khoury, Timothy E. Schlub, Kanta Subbarao, James A. Triccas and Wen Shi Lee and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Arnold Reynaldi

36 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

2021 2.1k citations David S. Khoury, Deborah Cromer et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arnold Reynaldi Australia	22	2.8k	811	502	470	352	36	3.6k
Jennifer A. Juno Australia	25	3.3k 1.2×	1.3k 1.6×	676 1.3×	470 1.0×	376 1.1×	81	4.7k
Wilfredo F. García-Beltrán United States	20	2.1k 0.8×	896 1.1×	829 1.7×	209 0.4×	274 0.8×	40	3.3k
Blake M. Hauser United States	16	2.3k 0.8×	419 0.5×	704 1.4×	202 0.4×	302 0.9×	51	2.8k
Jared Feldman United States	13	2.2k 0.8×	419 0.5×	702 1.4×	205 0.4×	299 0.8×	24	2.6k
Evan C. Lam United States	14	2.1k 0.7×	351 0.4×	558 1.1×	235 0.5×	277 0.8×	23	2.4k
Vivek Naranbhai United States	28	2.4k 0.8×	1.1k 1.4×	918 1.8×	197 0.4×	234 0.7×	78	4.0k
Nina Le Bert Singapore	23	2.2k 0.8×	1.1k 1.4×	706 1.4×	173 0.4×	164 0.5×	42	3.4k
Nisreen M.A. Okba Netherlands	20	3.4k 1.2×	367 0.5×	524 1.0×	83 0.2×	527 1.5×	28	3.8k
Corine H. GeurtsvanKessel Netherlands	30	2.3k 0.8×	1.3k 1.6×	530 1.1×	123 0.3×	134 0.4×	101	4.1k
Adeline Chia Singapore	20	2.1k 0.7×	1.3k 1.6×	621 1.2×	143 0.3×	155 0.4×	27	3.5k

Countries citing papers authored by Arnold Reynaldi

Since Specialization

Citations

This map shows the geographic impact of Arnold Reynaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Reynaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Reynaldi more than expected).

Fields of papers citing papers by Arnold Reynaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold Reynaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Reynaldi. The network helps show where Arnold Reynaldi may publish in the future.

Co-authorship network of co-authors of Arnold Reynaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Arnold Reynaldi. A scholar is included among the top collaborators of Arnold Reynaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold Reynaldi. Arnold Reynaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Trieu, Mai-Chi, Arnold Reynaldi, Wen Shi Lee, et al.. (2025). Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens. npj Vaccines. 10(1). 74–74. 1 indexed citations

Kent, Stephen J., Shiyao Li, Thakshila Amarasena, et al.. (2024). Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans. ACS Nano. 18(39). 27077–27089. 28 indexed citations

Selva, Kevin J., Ebene R. Haycroft, Arnold Reynaldi, et al.. (2023). Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections. JCI Insight. 8(18). 10 indexed citations

Cromer, Deborah, Arnold Reynaldi, Megan Steain, et al.. (2022). Relating In Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial. Clinical Infectious Diseases. 75(1). e878–e879. 13 indexed citations

Wragg, Kathleen M., Wen Shi Lee, Marios Koutsakos, et al.. (2022). Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory. Nature Immunology. 23(5). 768–780. 28 indexed citations

Kent, Stephen J., David S. Khoury, Arnold Reynaldi, et al.. (2022). Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?. Nature reviews. Immunology. 22(6). 387–397. 82 indexed citations

Koutsakos, Marios, Wen Shi Lee, Arnold Reynaldi, et al.. (2022). The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants. Immunity. 55(7). 1316–1326.e4. 23 indexed citations

Lee, Wen Shi, Arnold Reynaldi, Thakshila Amarasena, et al.. (2021). Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121. Frontiers in Immunology. 12. 749891–749891. 5 indexed citations

Khoury, David S., Deborah Cromer, Arnold Reynaldi, et al.. (2021). Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nature Medicine. 27(7). 1205–1211. 2105 indexed citations breakdown →

10.

Cromer, Deborah, Jennifer A. Juno, David S. Khoury, et al.. (2021). Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection. Nature reviews. Immunology. 21(6). 395–404. 167 indexed citations

11.

Lee, Wen Shi, Kevin J. Selva, Samantha K. Davis, et al.. (2021). Decay of Fc-dependent antibody functions after mild to moderate COVID-19. Cell Reports Medicine. 2(6). 100296–100296. 43 indexed citations

12.

Ju, Yi, Hannah G. Kelly, Laura F. Dagley, et al.. (2020). Person-Specific Biomolecular Coronas Modulate Nanoparticle Interactions with Immune Cells in Human Blood. ACS Nano. 14(11). 15723–15737. 91 indexed citations

13.

Khoury, David S., Adam K. Wheatley, Mitchell D. Ramuta, et al.. (2020). Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nature reviews. Immunology. 20(12). 727–738. 81 indexed citations

14.

Reynaldi, Arnold, Arlene E. Dent, Timothy E. Schlub, et al.. (2019). Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants. Malaria Journal. 18(1). 19–19. 10 indexed citations

15.

Parsons, Matthew S., Wen Shi Lee, Anne B. Kristensen, et al.. (2018). Fc-dependent functions are redundant to efficacy of anti-HIV antibody PGT121 in macaques. Journal of Clinical Investigation. 129(1). 182–191. 67 indexed citations

16.

Vanderven, Hillary A., Lu Liu, Fernanda Ana‐Sosa‐Batiz, et al.. (2017). Fc functional antibodies in humans with severe H7N9 and seasonal influenza. JCI Insight. 2(13). 40 indexed citations

17.

Fennessey, Christine M., Mykola Pinkevych, Taina T. Immonen, et al.. (2017). Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy. PLoS Pathogens. 13(5). e1006359–e1006359. 66 indexed citations

18.

Ortiz, Alexandra M., Diane G. Carnathan, Katherine M. Sheehan, et al.. (2016). Analysis of the In Vivo Turnover of CD4+ T-Cell Subsets in Chronically SIV-Infected Sooty Mangabeys. PLoS ONE. 11(5). e0156352–e0156352. 3 indexed citations

19.

Reynaldi, Arnold, Timothy E. Schlub, Erwan Piriou, et al.. (2016). Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection. The Journal of Infectious Diseases. 214(9). 1390–1398. 14 indexed citations

20.

Reynaldi, Arnold, Timothy E. Schlub, Kiprotich Chelimo, et al.. (2015). Impact ofPlasmodium falciparumCoinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children. The Journal of Infectious Diseases. 213(6). 985–991. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact